Gujarat Themis Biosyn Limited (GUJTHEM) — Announcement
Gujarat Themis Biosyn Limited announced its Investor Presentation on June 29, 2026, detailing strategic acquisitions and capacity expansion. The filing outlines plans to acquire Sanofi's anti-TB and anti-infective portfolio and MicroBiopharm Japan, aiming to expand into biologics and novel modalities while enhancing fermentation capabilities. Key financials show FY26 revenue of INR 16,582.28 lakhs and EBITDA margin of 45.55%. The presentation emphasizes forward integration from intermediates to finished dosage forms and geographic expansion into Europe and MEA markets. The company highlights strengthened R&D infrastructure and ESG initiatives as growth drivers. This move positions GTBL as a diversified pharma platform with enhanced manufacturing depth and global market access.
About Gujarat Themis Biosyn Limited (GUJTHEM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when GUJTHEM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GUJTHEM — Free💡 Ask AI about this filing
📊 More GUJTHEM filings
- 🔴 Insider Trading — 15 July 2026 Sachin D. Patel, promoter of Gujarat Themis Biosyn Limited, proposes to acquire up to 525,000 shares...
- regulation 31 — 14 July 2026 Pharmaceutical Business Group (India) Limited disclosed an indirect encumbrance on its 47.02% stake ...
- Announcement — 13 July 2026 Gujarat Themis Biosyn Limited disclosed that it has amicably settled a commercial arbitration disput...
- share transfer — 10 July 2026 Gujarat Themis Biosyn Limited received a SEBI-mandated certificate from MUFG Intime India confirming...
- 🟡 Voting Results — 10 July 2026 Gujarat Themis Biosyn Limited announced voting results for special resolutions passed via e-voting o...
🔥 Also filed on 29 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when GUJTHEM files new disclosures
Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GUJTHEM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research